313 filings
Page 7 of 16
8-K
APRE
Aprea Therapeutics Inc
16 May 22
Aprea Therapeutics Announces Acquisition of Atrin Pharmaceuticals Inc. and Reports First Quarter 2022 Financial Results
9:33am
10-K
2021 FY
APRE
Aprea Therapeutics Inc
Annual report
15 Mar 22
4:24pm
8-K
APRE
Aprea Therapeutics Inc
15 Mar 22
Aprea Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Update on Business Operations
4:23pm
4
APRE
Aprea Therapeutics Inc
14 Mar 22
Aprea Therapeutics / CHRISTIAN S SCHADE ownership change
5:03pm
4
APRE
Aprea Therapeutics Inc
14 Mar 22
Aprea Therapeutics / Gregory Alan Korbel ownership change
5:03pm
4
Coiante Scott M
14 Mar 22
Aprea Therapeutics / Scott M Coiante ownership change
5:02pm
4
APRE
Aprea Therapeutics Inc
14 Mar 22
Aprea Therapeutics / Eyal C. Attar ownership change
5:01pm
4
Abrahmsen Lars B.
14 Mar 22
Aprea Therapeutics / Lars B. Abrahmsen ownership change
5:01pm
4
Schade Christian S
1 Mar 22
Aprea Therapeutics / CHRISTIAN S SCHADE ownership change
5:02pm
4
APRE
Aprea Therapeutics Inc
1 Mar 22
Aprea Therapeutics / Scott M Coiante ownership change
5:01pm
4
Attar Eyal C.
1 Mar 22
Aprea Therapeutics / Eyal C. Attar ownership change
5:01pm
4
Korbel Gregory Alan
1 Mar 22
Aprea Therapeutics / Gregory Alan Korbel ownership change
12:00am
SC 13G/A
APRE
Aprea Therapeutics Inc
14 Feb 22
Aprea Therapeutics / Redmile ownership change
12:00am
SC 13G/A
APRE
Aprea Therapeutics Inc
11 Feb 22
Aprea Therapeutics / Versant Ventures V ownership change
12:00am
8-K
APRE
Aprea Therapeutics Inc
13 Jan 22
J.P. Morgan 40 th Annual Healthcare Conference January 2022
8:00am
8-K
APRE
Aprea Therapeutics Inc
9 Dec 21
Aprea Therapeutics Announces Removal of FDA Clinical Hold on Eprenetapopt in Lymphoid Malignancies
4:30pm
4
Korbel Gregory Alan
3 Dec 21
Aprea Therapeutics / Gregory Alan Korbel ownership change
5:01pm
S-8
APRE
Aprea Therapeutics Inc
9 Nov 21
Registration of securities for employees
12:00am
10-Q
2021 Q3
APRE
Aprea Therapeutics Inc
Quarterly report
8 Nov 21
4:30pm